Inventor
HAMBLETON JULIE
US11 patents
Patents
11 patentsUS9765147B2Sep 19, 2017
Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC25 citations93
US10618967B2Apr 14, 2020
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC5 citations83
US10221244B2Mar 5, 2019
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC10 citations83
US10172937B2Jan 8, 2019
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies
FIVE PRIME THERAPEUTICS INC5 citations80
US10040858B2Aug 7, 2018
Anti-CSF1R antibodies for treating PVNS
FIVE PRIME THERAPEUTICS INC2 citations68
US11566076B2Jan 31, 2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
FIVE PRIME THERAPEUTICS INC0 citations61
US12465636B2Nov 11, 2025
Method of making afucosylated anti-FGFR2IIIB antibodies
FIVE PRIME THERAPEUTICS INC0 citations58
US11235059B2Feb 1, 2022
Afucosylated anti-FGFR2IIIB antibodies
FIVE PRIME THERAPEUTICS INC0 citations58
US10730949B2Aug 4, 2020
Method of treating PVNS with anti-CSF1R antibodies
FIVE PRIME THERAPEUTICS INC1 citations58
US10975153B2Apr 13, 2021
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
FIVE PRIME THERAPEUTICS INC1 citations57
US11421034B2Aug 23, 2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
FIVE PRIME THERAPEUTICS INC0 citations46